WCG IRB has contractual relationships with over 3,100 academic medical centers, hospitals and research institutions. Our partners in clinical research leverage this network to efficiently drive submission and review activity, and streamline trial activation.
Example: Phase II Crohn’s Disease Study
In the example below, we examine a study that did not leverage that centralized network, and show the comparative benefits if the study had leveraged WCG IRB for streamlined review and centralized process.
This study was conducted without using the WCG IRB central submission process, adding significantly to their IRB review turnaround time (TAT).